EGA
JNP

Eagle Global Advisors’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Eagle Global Advisors’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-44,442
Closed -$247K – 423
2016
Q3 		$247K Buy
44,442
+10,070
+29% +$66.6K 0.01% 291
2016
Q2 		$241K Buy
+34,372
New +$242K 0.01% 297

Other funds holding JNP

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return

Eagle Global Advisors's JNP Position: Q4 2016 in Review

Eagle Global Advisors sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q4 2016, closing a stake of 44,442 shares — an estimated $247K sold.

Eagle Global Advisors first reported a position in JNP in Q2 2016 and held it in 2 quarters. The position peaked at $247K in Q3 2016. 40 funds tracked by Wall St. Rank hold JNP as of Q4 2016.

  • Eagle Global Advisors reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Eagle Global Advisors sold 44,442 Juniper Pharmaceuticals, Inc. Common Stock shares in Q4 2016, an estimated $247K.
  • Eagle Global Advisors first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q2 2016 and held it in 2 quarters.
  • Eagle Global Advisors's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $247K in Q3 2016.
  • 40 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q4 2016.

Based on Eagle Global Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.